4MT-04 Series

N/A

Report date: 2024/03/14 15:24:37

Base Information

Drug Name4MT-04 Series
Drug Alias Name4MT-04 Series
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 5 inhibitors
TargetsCyclin-dependent kinase 5
Therapy Area/IndicationsNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies4M Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies4M Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeurodegenerative Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A